Article
CMS drops appeal of Stark ruling on lithotripsy
Washington-The Centers for Medicare and Medicaid Services has dropped its appeal of a recent U.S. District Court ruling that lithotripsy should not be encompassed within the Stark II ban on physician self-referrals. With the withdrawal, the court's decision on the matter is final, according to the attorney representing the American Lithotripsy Society (ALS) and Urology Society of America (USA).
Related Videos
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
An Overview Of Pembrolizumab for High-Risk BCG Unresponsive NMIBC
Case 2: A 63-Year-Old Man With Recurrent HSPC
Comorbidities and Adherence: Tailoring mHSPC Treatment
FDA-Approved Options for High-Risk BCG-Unresponsive NMIBC
De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment
Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
Alternative treatments and patient communication for genitourinary syndrome of menopause
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
Prostate cancer screening: Expert weighs in after Biden's diagnosis
Related Content
